Microlin Bio, Inc. to Present at 2016 Marcum MicroCap Conference
May 31, 2016 13:41 ET
|
Microlin Bio, Inc.
NEW YORK, May 31, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc.(OTCQB:MICB), a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today...
Microlin Bio, Inc. Announces Termination of Planned Marina Biotech Asset Purchase
May 02, 2016 23:41 ET
|
Microlin Bio, Inc.
NEW YORK, May 02, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc. (OTCQB:MICB), a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today...
Microlin Bio Signs Exclusive License and Research Agreement With Université Laval to Develop microRNA-Based Treatments for Alzheimer’s Disease
February 10, 2016 11:55 ET
|
Microlin Bio, Inc.
NEW YORK and QUEBEC CITY, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc. (Microlin) (OTCBB:MICB) and Université Laval, today announced that they have entered into an exclusive license and...
Microlin Bio, Inc. Announces Ticker Symbol Change to MICB
January 14, 2016 09:28 ET
|
Microlin Bio, Inc.
NEW YORK, Jan. 14, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today announced the...
Microlin Bio, Inc. Announces Publication of Results From AntimiR-21 Lung Cancer Study in Molecular Pharmaceutics
January 12, 2016 08:00 ET
|
Microlin Bio, Inc.
NEW YORK, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Microlin Bio, Inc.(OTCQB:AMIB), a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today...
Microlin Bio, Inc. Completes Reverse Merger and Becomes a Publicly Traded Company
December 22, 2015 16:30 ET
|
Microlin Bio, Inc.
NEW YORK, Dec. 22, 2015 (GLOBE NEWSWIRE) -- Microlin Bio, Inc., a development stage biotechnology company focused on the development of microRNA based therapeutics for cancer, today announced the...